These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 29895791)

  • 21. Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages.
    Cisek AA; Dąbrowska I; Gregorczyk KP; Wyżewski Z
    Curr Microbiol; 2017 Feb; 74(2):277-283. PubMed ID: 27896482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Phage therapy: a realistic weapon against multidrug resistant bacteria].
    Dufour N; Debarbieux L
    Med Sci (Paris); 2017 Apr; 33(4):410-416. PubMed ID: 28497737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological challenges of phage therapy and proposed solutions: a literature review.
    Caflisch KM; Suh GA; Patel R
    Expert Rev Anti Infect Ther; 2019 Dec; 17(12):1011-1041. PubMed ID: 31735090
    [No Abstract]   [Full Text] [Related]  

  • 24. Bacteriophages and their derivatives for the treatment and control of food-producing animal infections.
    Carvalho C; Costa AR; Silva F; Oliveira A
    Crit Rev Microbiol; 2017 Sep; 43(5):583-601. PubMed ID: 28071145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phage therapy for bacterial infection of burn].
    Peng YZ; Huang GT
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):513-6. PubMed ID: 27647065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors determining phage stability/activity: challenges in practical phage application.
    Jończyk-Matysiak E; Łodej N; Kula D; Owczarek B; Orwat F; Międzybrodzki R; Neuberg J; Bagińska N; Weber-Dąbrowska B; Górski A
    Expert Rev Anti Infect Ther; 2019 Aug; 17(8):583-606. PubMed ID: 31322022
    [No Abstract]   [Full Text] [Related]  

  • 27. Optimizing the Timing and Composition of Therapeutic Phage Cocktails: A Control-Theoretic Approach.
    Li G; Leung CY; Wardi Y; Debarbieux L; Weitz JS
    Bull Math Biol; 2020 Jun; 82(6):75. PubMed ID: 32533350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phage-bacterial evolutionary interactions: experimental models and complications.
    Oyejobi GK; Zhang X; Xiong D; Ogolla F; Xue H; Wei H
    Crit Rev Microbiol; 2023 Mar; 49(2):283-296. PubMed ID: 35358006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phages and their potential to modulate the microbiome and immunity.
    Federici S; Nobs SP; Elinav E
    Cell Mol Immunol; 2021 Apr; 18(4):889-904. PubMed ID: 32901128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards Inhaled Phage Therapy in Western Europe.
    Wienhold SM; Lienau J; Witzenrath M
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30909579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of phages, bacteria, and the human immune system: Evolutionary changes in phage therapy.
    Jariah ROA; Hakim MS
    Rev Med Virol; 2019 Sep; 29(5):e2055. PubMed ID: 31145517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phages Needed against Resistant Bacteria.
    Moelling K
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32664292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flagellotropic Bacteriophages: Opportunities and Challenges for Antimicrobial Applications.
    Esteves NC; Scharf BE
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phage Therapy in the Twenty-First Century: Facing the Decline of the Antibiotic Era; Is It Finally Time for the Age of the Phage?
    Hesse S; Adhya S
    Annu Rev Microbiol; 2019 Sep; 73():155-174. PubMed ID: 31185183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ameliorating the antimicrobial resistance crisis: phage therapy.
    Saha D; Mukherjee R
    IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naturally-occurring and cultured bacteriophages in human therapy.
    Kiani AK; Anpilogov K; Dhuli K; Paolacci S; Benedetti S; Manara E; Guerri G; Dautaj A; Beccari T; Dundar M; Bertelli M
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(1 Suppl):101-107. PubMed ID: 34890040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hurdles for Phage Therapy to Become a Reality-An Editorial Comment.
    Brüssow H
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31212885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018.
    Lemon DJ; Kay MK; Titus JK; Ford AA; Chen W; Hamlin NJ; Hwang YY
    J Microbiol; 2019 Jun; 57(6):532-538. PubMed ID: 31054139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteriophages and its applications: an overview.
    Sharma S; Chatterjee S; Datta S; Prasad R; Dubey D; Prasad RK; Vairale MG
    Folia Microbiol (Praha); 2017 Jan; 62(1):17-55. PubMed ID: 27718043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitigation of evolved bacterial resistance to phage therapy.
    Torres-Barceló C; Turner PE; Buckling A
    Curr Opin Virol; 2022 Apr; 53():101201. PubMed ID: 35180532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.